Suppr超能文献

降主动脉瘤破裂血管内修复的早期经验

Early Experiences with the Endovascular Repair of Ruptured Descending Thoracic Aortic Aneurysm.

作者信息

Choi Jae-Sung, Oh Se Jin, Sung Yong Won, Moon Hyun Jong, Lee Jung Sang

机构信息

Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center.

出版信息

Korean J Thorac Cardiovasc Surg. 2016 Apr;49(2):73-9. doi: 10.5090/kjtcs.2016.49.2.73. Epub 2016 Apr 5.

Abstract

BACKGROUND

The aim of this study was to report our early experiences with the endovascular repair of ruptured descending thoracic aortic aneurysms (rDTAAs), which are a rare and life-threatening condition.

METHODS

Among 42 patients who underwent thoracic endovascular aortic repair (TEVAR) between October 2010 and September 2015, five patients (11.9%) suffered an rDTAA.

RESULTS

The mean age was 72.4±5.1 years, and all patients were male. Hemoptysis and hemothorax were present in three (60%) and two (40%) patients, respectively. Hypovolemic shock was noted in three patients who underwent emergency operations. A hybrid operation was performed in three patients. The mean operative time was 269.8±72.3 minutes. The mean total length of aortic coverage was 186.0±49.2 mm. No 30-day mortality occurred. Stroke, delirium, and atrial fibrillation were observed in one patient each. Paraplegia did not occur. Endoleak was found in two patients (40%), one of whom underwent an early and successful reintervention. During the mean follow-up period of 16.8±14.8 months, two patients died; one cause of death was a persistent type 1 endoleak and the other cause was unknown.

CONCLUSION

TEVAR for rDTAA was associated with favorable early mortality and morbidity outcomes. However, early reintervention should be considered if persistent endoleak occurs.

摘要

背景

本研究的目的是报告我们对破裂性降主动脉瘤(rDTAAs)进行血管内修复的早期经验,rDTAAs是一种罕见且危及生命的疾病。

方法

在2010年10月至2015年9月期间接受胸主动脉腔内修复术(TEVAR)的42例患者中,有5例(11.9%)患有rDTAA。

结果

平均年龄为72.4±5.1岁,所有患者均为男性。咯血和血胸分别出现在3例(60%)和2例(40%)患者中。3例接受急诊手术的患者出现了低血容量性休克。3例患者接受了杂交手术。平均手术时间为269.8±72.3分钟。主动脉覆盖的平均总长度为186.0±49.2毫米。无30天死亡率。分别有1例患者出现中风、谵妄和心房颤动。未发生截瘫。2例患者(40%)发现内漏,其中1例早期成功进行了再次干预。在平均16.8±14.8个月的随访期内,2例患者死亡;1例死亡原因是持续性I型内漏,另1例死亡原因不明。

结论

rDTAA的TEVAR与良好的早期死亡率和发病率结果相关。然而,如果发生持续性内漏,应考虑早期再次干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4825906/2829344211c8/kjtcv-49-073f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验